Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
1.800
-0.030 (-1.64%)
Streaming Delayed Price
Updated: 11:13 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test
September 29, 2022
Patients didn't show any improvements in a study meant to test multiple drugs.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Stock Sees Relative Strength Rating Rise To 98
September 09, 2022
Amylyx Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating improve to 98, up from 83 the day before.
Via
Investor's Business Daily
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...
Via
Benzinga
4 Analysts Have This to Say About Amylyx Pharma
September 08, 2022
Analysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:
Via
Benzinga
After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful
September 08, 2022
Via
Benzinga
US Stocks Flat, Crude Oil Rises 2%
September 08, 2022
U.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data.
Via
Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
September 08, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Via
Benzinga
US Stocks Turn Higher, Nasdaq Jumps 100 Points
September 08, 2022
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.
Via
Benzinga
Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today?
September 08, 2022
Amylyx Pharmaceuticals (AMLX) stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment.
Via
InvestorPlace
FDA Again Highlights Lacking Data From Amylyx's Amyotrophic Lateral Sclerosis Candidate
September 06, 2022
Via
Benzinga
The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Stock Off A Cliff
September 02, 2022
The FDA's advisors will meet Wednesday to discuss the experimental ALS treatment.
Via
Investor's Business Daily
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
September 08, 2022
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
AAPL Stock Alert: 13 Takeaways From the Latest Apple Event 2022
September 08, 2022
Apple (AAPL) stock is a hot topic on Thursday following the tech giant's latest event showing off new products and we've got the details!
Via
InvestorPlace
Dow Drops 100 Points; US Jobless Claims Fall Further Last Week
September 08, 2022
U.S. stocks traded mostly lower this morning, with the Dow Jones dropping 100 points on Thursday.
Via
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.
Via
Benzinga
Why IPO Stock Amylyx Pharmaceuticals Is Beginning To Heat Up — Again
July 05, 2022
Could this FDA action turn things around for Amylyx in September?
Via
Investor's Business Daily
Here's How Citi Views Amylyx Pharma
June 14, 2022
Via
Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
September 06, 2022
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Via
Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
What 4 Analyst Ratings Have To Say About Amylyx Pharma
June 14, 2022
Within the last quarter, Amylyx Pharma (NASDAQ:AMLX) has observed the following analyst ratings:
Via
Benzinga
Why Stealth BioTherapeutics Shares Are Surging Today?
June 08, 2022
Via
Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.
Via
InvestorPlace
Why Is Novavax (NVAX) Stock Rallying Today?
July 05, 2022
Novavax (NVAX) stock is taking off on Tuesday after the vaccine company got approval for the expanded use of its Covid-19 vaccine in Europe.
Via
InvestorPlace
Amylyx (AMLX) Stock Spikes 13% as FDA Resumes Discussion of ALS Drug
July 05, 2022
A new wrinkle in the story of Amylyx Pharmaceuticals' ongoing battle against ALS bodes well for patients, and for AMLX stock holders.
Via
InvestorPlace
Amylyx Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
June 28, 2022
Amylyx Pharmaceuticals stock reached an key technical benchmark, with its Relative Strength Rating climbing to 95, up from 70 the day before.
Via
Investor's Business Daily
Canada Approves Amylyx's ALS Drug; FDA To Consider Approval In September
June 13, 2022
The Canadian government has given its approval to AMX0035, a new drug from Cambridge, Massachusetts-based Amylyx Pharmaceuticals Inc.
Via
Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
July 05, 2022
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Via
Benzinga
82 Biggest Movers From Yesterday
June 15, 2022
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
Via
Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.